Coya Therapeutics Inc (COYA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$4.76+4.62%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · COYA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 8.0 | 7.9 | 3.6 | 6.0 | 0.0 | — | — |
| Total Revenues | 8.0 | 7.9 | 3.6 | 6.0 | 0.0 | — | — |
| Operating Expenses & Income | |||||||
| Operating Income | (23.2) | (22.6) | (17.2) | (7.9) | (9.8) | (4.9) | — |
| Earnings from Continuing Operations | |||||||
| EBT, Incl. Unusual Items | — | (21.2) | (15.6) | (7.3) | (12.2) | — | — |
| Income Tax Expense | — | 0.0 | (0.7) | 0.7 | 0.0 | — | — |
| Net Income | |||||||
| Net Income | (21.7) | (21.2) | (14.9) | (8.0) | (12.2) | (4.9) | — |
| Per Share | |||||||
| Basic EPS | (0.92) | (1.27) | (0.98) | (0.79) | (4.73) | (1.89) | — |
| Diluted EPS | (0.92) | (1.27) | (0.98) | (0.79) | (4.73) | (1.89) | — |
| Revenue per Share | 0.34 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 23.5 | 16.7 | 15.2 | 10.2 | 2.6 | 2.6 | — |
| Diluted Weighted Avg Shares | 23.5 | 16.7 | 15.2 | 10.2 | 2.6 | 2.6 | — |
| Supplemental | |||||||
| EBIT | (23.2) | (22.6) | (17.2) | (7.9) | (9.8) | (4.9) | — |
| Effective Tax Rate | — | — | — | -10.0% | 0.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.